cyclopentane has been researched along with Emergencies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnkrant, D; Cox, E | 1 |
| Boltz, DA; Castillo, R; Holland, LE | 1 |
| Fujisaki, T; Kubo, T; Muta, T; Nakanishi, H; Yokota, E; Yoshitomi, R | 1 |
| Kawakami, K; Matsui, S; Urushihara, H | 1 |
2 review(s) available for cyclopentane and Emergencies
| Article | Year |
|---|---|
Peramivir and its use in H1N1 influenza.
Topics: Acids, Carbocyclic; Antiviral Agents; Clinical Trials as Topic; Cyclopentanes; Emergencies; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Oseltamivir; United States; United States Food and Drug Administration | 2010 |
Emergency authorization of medical products: regulatory challenges from the 2009 H1N1 influenza pandemic in Japan.
Topics: Acids, Carbocyclic; Antiviral Agents; Cyclopentanes; Drug Approval; Emergencies; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Japan; Pandemics; United States | 2012 |
2 other study(ies) available for cyclopentane and Emergencies
| Article | Year |
|---|---|
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
Topics: Acids, Carbocyclic; Antiviral Agents; Cyclopentanes; Drug Approval; Drugs, Investigational; Emergencies; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Injections, Intravenous; Investigational New Drug Application; Neuraminidase; United States; United States Food and Drug Administration | 2009 |
Pandemic (H1N1) 2009-associated ARDS rescued by neuraminidase inhibitors with emergency use of extracorporeal membrane oxygenation.
Topics: Acids, Carbocyclic; Adult; Anemia, Hemolytic, Autoimmune; Antiviral Agents; Combined Modality Therapy; Cyclopentanes; Disease Outbreaks; Emergencies; Extracorporeal Membrane Oxygenation; Guanidines; Humans; Immunocompromised Host; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lupus Erythematosus, Systemic; Male; Neuraminidase; Oxygen Inhalation Therapy; Prednisolone; Radiography; Respiration, Artificial; Respiratory Distress Syndrome; Viral Proteins | 2010 |